• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人群中特定年龄的失明和视力损害患病率及病因:鹿特丹研究

Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study.

作者信息

Klaver C C, Wolfs R C, Vingerling J R, Hofman A, de Jong P T

机构信息

Department of Epidemiology and Biostatistics, Erasmus University Medical School, Rotterdam, The Netherlands.

出版信息

Arch Ophthalmol. 1998 May;116(5):653-8. doi: 10.1001/archopht.116.5.653.

DOI:10.1001/archopht.116.5.653
PMID:9596502
Abstract

OBJECTIVE

To study the prevalence and causes of blindness and visual impairment in various age categories of a large population-based study.

METHODS

For the study, 6775 subjects aged 55 years or older underwent an extensive ophthalmologic screening examination, including measurements of visual acuity and the visual field and fundus photography. The causes of blindness or visual impairment were determined using all screening information and medical records.

RESULTS

The prevalence of blindness, according to World Health Organization criteria, ranged from 0.1% in subjects aged 55 to 64 years to 3.9% in subjects aged 85 years or older; the prevalence of visual impairment ranged from 0.1% to 11.8%. For persons younger than 75 years, myopic degeneration and optic neuropathy were the most important causes of impaired vision. For persons aged 75 years or older, age-related macular degeneration was the major cause of the increased prevalence of blindness, whereas age-related cataract predominantly caused the increased prevalence of visual impairment.

CONCLUSIONS

The hierarchy of causes of blindness and visual impairment is highly determined by age. As yet, little can be done to reduce the exponential increase of blindness; however, adequate implementation of surgery to treat cataract could reduce visual impairment by one third. Underuse of ophthalmologic care is a prominent cause of the high frequency of untreated cataracts among the elderly.

摘要

目的

在一项基于大规模人群的研究中,研究不同年龄组失明和视力损害的患病率及病因。

方法

在该研究中,6775名55岁及以上的受试者接受了全面的眼科筛查检查,包括视力、视野测量和眼底照相。利用所有筛查信息和病历确定失明或视力损害的病因。

结果

根据世界卫生组织标准,失明患病率在55至64岁受试者中为0.1%,在85岁及以上受试者中为3.9%;视力损害患病率在0.1%至11.8%之间。对于75岁以下的人,近视性变性和视神经病变是视力受损的最重要原因。对于75岁及以上的人,年龄相关性黄斑变性是失明患病率增加的主要原因,而年龄相关性白内障主要导致视力损害患病率增加。

结论

失明和视力损害的病因层级很大程度上由年龄决定。目前,几乎无法减少失明人数的指数增长;然而,充分实施白内障手术可将视力损害降低三分之一。眼科护理利用不足是老年人白内障未治疗率高的一个突出原因。

相似文献

1
Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study.老年人群中特定年龄的失明和视力损害患病率及病因:鹿特丹研究
Arch Ophthalmol. 1998 May;116(5):653-8. doi: 10.1001/archopht.116.5.653.
2
Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study.北京城乡地区失明和视力损伤的病因:北京眼病研究
Ophthalmology. 2006 Jul;113(7):1134.e1-11. doi: 10.1016/j.ophtha.2006.01.035. Epub 2006 May 2.
3
Prevalence and causes of visual impairment and blindness among 9980 Scandinavian adults: the Copenhagen City Eye Study.9980名斯堪的纳维亚成年人视力损害和失明的患病率及原因:哥本哈根市眼病研究
Ophthalmology. 2004 Jan;111(1):53-61. doi: 10.1016/j.ophtha.2003.05.010.
4
Prevalence and causes of visual impairment in an elderly Chinese population in Taiwan: the Shihpai Eye Study.台湾石牌地区老年人群视力损害的患病率及原因:石牌眼科研究
Ophthalmology. 2004 Jan;111(1):62-9. doi: 10.1016/j.ophtha.2003.05.011.
5
[Visual impairment and blindness in Icelanders aged 50 years and older - the Reykjavík Eye Study].[冰岛50岁及以上人群的视力损害和失明——雷克雅未克眼科研究]
Laeknabladid. 2013 Mar;99(3):123-7. doi: 10.17992/lbl.2013.03.486.
6
Prevalence and causes of blindness and visual impairment in Bangladeshi adults: results of the National Blindness and Low Vision Survey of Bangladesh.孟加拉国成年人失明和视力损害的患病率及原因:孟加拉国全国失明和视力低下调查结果
Br J Ophthalmol. 2003 Jul;87(7):820-8. doi: 10.1136/bjo.87.7.820.
7
Prevalence Factors Associated With Vision Impairment and Blindness Among Individuals 85 Years and Older in Russia.俄罗斯 85 岁及以上人群视力障碍和失明的相关流行因素。
JAMA Netw Open. 2021 Aug 2;4(8):e2121138. doi: 10.1001/jamanetworkopen.2021.21138.
8
Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study.澳大利亚的视力及视力丧失原因。蓝山眼研究。
Ophthalmology. 1996 Mar;103(3):357-64. doi: 10.1016/s0161-6420(96)30684-2.
9
Prevalence and causes of visual impairment and blindness in Icelanders aged 50 years and older: the Reykjavik Eye Study.冰岛50岁及以上人群视力损害和失明的患病率及原因:雷克雅未克眼部研究
Acta Ophthalmol. 2008 Nov;86(7):778-85. doi: 10.1111/j.1755-3768.2008.01191.x. Epub 2008 May 30.
10
Prevalence and Causes of Visual Impairment in Adults in Binhu District, Wuxi, China.中国无锡市滨湖区成年人视力障碍的患病率及病因。
Med Sci Monit. 2018 Jan 16;24:317-323. doi: 10.12659/msm.908218.

引用本文的文献

1
Characteristics of Myopic Traction Maculopathy in the Aier-SERI High Myopia Adult Cohort Study.爱尔- SERI高度近视成人队列研究中近视性牵引性黄斑病变的特征
Ophthalmol Sci. 2025 Jul 24;5(6):100894. doi: 10.1016/j.xops.2025.100894. eCollection 2025 Nov-Dec.
2
Ocular Complications of Myopia: Bibliometric Analysis and Citation Networks.近视的眼部并发症:文献计量分析与引文网络
Reports (MDPI). 2023 Jun 1;6(2):26. doi: 10.3390/reports6020026.
3
Double Myopic Choroidal Neovascular Membranes (CNVMs): A Case Report.双眼近视性脉络膜新生血管膜(CNVMs):一例报告
Cureus. 2025 Jun 22;17(6):e86567. doi: 10.7759/cureus.86567. eCollection 2025 Jun.
4
Real-Life Treatment Intervals and Morphological Outcomes Following the Switch to Faricimab Therapy in Neovascular Age-Related Macular Degeneration.湿性年龄相关性黄斑变性患者转换为faricimab治疗后的实际治疗间隔和形态学结果
J Pers Med. 2025 May 6;15(5):189. doi: 10.3390/jpm15050189.
5
Use of SGLT2 Inhibitors Versus DPP-4 Inhibitors and Age-Related Macular Degeneration in Patients WithType 2 Diabetes: A Multinational Cohort Study.2型糖尿病患者中钠-葡萄糖协同转运蛋白2抑制剂与二肽基肽酶-4抑制剂的使用及年龄相关性黄斑变性:一项多国队列研究
Invest Ophthalmol Vis Sci. 2025 Apr 1;66(4):58. doi: 10.1167/iovs.66.4.58.
6
Twelve month refractive and axial length changes in the Israeli refractive error, activity, and devices (iREAD) study.以色列屈光不正、活动与设备(iREAD)研究中12个月的屈光和眼轴长度变化
Sci Rep. 2025 Apr 14;15(1):12778. doi: 10.1038/s41598-025-97336-1.
7
Annual Trend of Myopia and High Myopia in Children in Japan: A Nationwide Claims Database Study.日本儿童近视和高度近视的年度趋势:一项全国性索赔数据库研究
Ophthalmol Sci. 2025 Feb 3;5(4):100729. doi: 10.1016/j.xops.2025.100729. eCollection 2025 Jul-Aug.
8
Long-term visual outcomes of patients with neovascular age-related macular degeneration treated with anti-VEGF therapy lost to follow-up.接受抗血管内皮生长因子(VEGF)治疗但失访的新生血管性年龄相关性黄斑变性患者的长期视觉预后
Graefes Arch Clin Exp Ophthalmol. 2025 Mar 20. doi: 10.1007/s00417-025-06798-6.
9
Insignificant difference in medication adherence to dyslipidemia drugs between visually impaired and non-disabled people in South Korea: A nationwide cohort study using claims records.韩国视障人士与非残疾人士在血脂异常药物治疗依从性方面无显著差异:一项使用理赔记录的全国性队列研究。
PLoS One. 2025 Jan 8;20(1):e0307764. doi: 10.1371/journal.pone.0307764. eCollection 2025.
10
The Screening Visual Complaints questionnaire-acquired brain injury: Development and evaluation of psychometric properties in a community sample.筛查视觉障碍问卷-获得性脑损伤:社区样本中测量学特性的开发与评估
PLoS One. 2024 Dec 31;19(12):e0314999. doi: 10.1371/journal.pone.0314999. eCollection 2024.